Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact.

@article{Myerburg1998InterpretationOO,
  title={Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact.},
  author={Robert Jerome Myerburg and Raul David Mitrani and Alberto Interian and Agustin Castellanos},
  journal={Circulation},
  year={1998},
  volume={97 15},
  pages={1514-21}
}
The results of the Cardiac Arrhythmia Suppression Trials (CAST and CAST II) were a watershed in attitudes about management of cardiac arrhythmias. 1–3 On the basis of the then-prevailing assumption that premature ventricular contractions (PVCs) in the presence of recent myocardial infarction identified a risk for life-threatening arrhythmias and that they also served as the trigger for fatal arrhythmias, it was logical to determine whether suppression of ambient arrhythmias would protect… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 67 extracted citations

Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress

Cardiology research and practice • 2016
View 9 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 32 references

A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near - fatal ventricular arrhythmias

AJ Moss, WJ Hall, +9 authors M Heo
N Engl J Med • 1997

CABG Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery

Bigger JT
N Engl J Med • 1997

Carvedilol Heart Failure Study Group . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure

MR Bristow, EM Gilbert, +9 authors N Shusterman
N Engl J Med • 1996

Similar Papers

Loading similar papers…